Scientists to improve food plant worker safety, product supply

Cornell University
26-Oct-2020 3:10 PM EDT, by Cornell University

Newswise — ITHACA, N.Y. – The COVID-19 pandemic has threatened the nation’s food supply, in part due to food industry workers falling ill, which reduces the workforce and can lead to temporary facility shut-downs.

A Cornell University-led project will use computer modeling and outreach to find optimal strategies to minimize COVID-19 cases and transmission among workers in food processing facilities, while maintaining the best possible production.

Researchers will collaborate with a dozen meat, dairy and produce industry partners to explore potential solutions in real-world settings.

“This is a problem that requires rapid solutions, we need to solve this right now,” said project principal investigator Renata Ivanek, associate professor in the College of Veterinary Medicine’s Department of Population Medicine and Diagnostic Sciences.

Though the hope is that the pandemic will be quelled in the next year, Ivanek said the project will address current issues while also providing valuable insights for any future disease outbreaks.

Food production is an essential industry. Keeping workers safe is a priority and a challenge since they often need to work in close proximity to each other, increasing the risk of COVID-19 transmission. Many companies have tried to address the risk by shutting down a portion of their production lines and adding plexiglass dividers but this reduces production capacity. Adding to the complexity is that facilities are all unique.  

“Part of the project is to investigate how segments of the food production industry differ and how to develop control strategies that will fit a specific industry segment,” Ivanek said.

Once a model has been developed and validated, it will be scaled up and applied in several specific facilities to further validate it in real world settings. Industry partners include produce processors Misionero Vegetables, Del Monte Foods, Seneca Foods Corporation and Taylor Farms; dairy processor Great Lakes Cheese; and poultry, beef and pork processor Tyson Foods.

In parallel, co-principal investigators, Samuel Alcaine, assistant professor of food science, and Martin Wiedmann, professor of food safety, will develop and deliver online extension programs for industries.

Outreach will include courses on COVID-19, its biology and how to control it. The Institute for Food Safety at Cornell University has already begun some of this work, including information-sharing office hours that food processing facility managers may virtually join to engage with COVID-19 experts on such topics as safety training for employees and using checklists to assess a facility’s safety plan.

The project was made possible thanks to a two-year, $1 million rapid-response grant from the United States Department of Agriculture’s National Institute of Food and Agriculture.

For additional information, see this Cornell Chronicle story.

-30-




Filters close

Showing results

1120 of 4578
Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Released: 15-Jan-2021 11:20 AM EST
Will Covid-19 kill the high street once and for all?
University of Sheffield

The shift to home working during Covid-19, or ‘Zoomshock’, threatens the survival of local goods and services provided in city centres and business parks

14-Jan-2021 5:00 PM EST
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
Association of American Cancer Institutes (AACI)

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

Released: 15-Jan-2021 8:55 AM EST
The First Dose of the Pfizer Vaccine Gives About 50% COVID Protection, Not 91% Claimed by Those Who Want to Speed Up Immunization
Newswise

The NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.

Released: 15-Jan-2021 8:20 AM EST
Houston Methodist study finds males of all ages more affected by COVID-19 than females
Houston Methodist

A new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary journal published by the Public Library of Science.

Released: 15-Jan-2021 8:20 AM EST
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers


Showing results

1120 of 4578

close
1.24254